Skip to main content
Toggle navigation
Search
Home
Icon Legend
Food/Drinks Available
CE's Available
Reception
Pre-registration Required
Livestreaming
Recorded Session
Back
Tweet this
Apurva Oak
Poster(s):
(216) Approved drug lubiprostone is not a selective Clc-2 activator and its prosecretory effect primarily depends on CFTR in human intestinal epithelial cells
Thursday, November 3, 2022
12:00 PM – 12:40 PM
ET
